MedTrace Logo

A Human Clinical Trial Evaluating the Effect of MealShape™ on Blood Glucose Level Following Consumption of Standard Meal

NCT02074423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2014-02-28

No results posted yet for this study

Summary

The purpose of the study is to evaluate the effect of MealShape, a Ceylon cinnamon extract (Cinnamomum zeylanicum) on blood glucose and insulin response after consumption of a standard meal composed of white bread, in healthy male and female volunteers.

Conditions

  • Postprandial Glycemia
  • Postprandial Insulinemia

Interventions

DIETARY_SUPPLEMENT

MealShape cinnamon extract

Acute administration of 1 g PO (2 capsules of 500 mg)

DIETARY_SUPPLEMENT

Placebo

Acute administration of 1 g PO (2 capsules of 500 mg)

Sponsors & Collaborators

  • Dialpha

    lead OTHER

Principal Investigators

  • Xavier Deplanque · Naturalpha

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • France

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02074423 on ClinicalTrials.gov